Related Experiment Video
Updated: Aug 16, 2025

08:11
Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
8.4K
Bioinformatics analysis: relationship between adrenocortical carcinoma and KIFs
Xiao Li1, Yanghao Tai2, Shuying Liu1
1Department of Thoracic Oncology, Linfen Central Hospital, Linfen, China.
Biotechnology & Genetic Engineering Reviews
|December 27, 2022
Summary
Kinin superfamily (KIF) genes like KIF4A, KIF11, KIF20A, and KIF22 are linked to adrenocortical carcinoma (ACC) progression and immune cell infiltration, offering new diagnostic and management strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Adrenocortical carcinoma (ACC) has a low incidence and poor prognosis despite surgical treatment.
- The role of the kinin superfamily (KIF) in ACC, particularly regarding prognosis and immune cell infiltration, is not well understood.
Purpose of the Study:
- To investigate the prognostic value and immune cell infiltration of KIFs in adrenocortical carcinoma.
- To identify key KIF genes associated with ACC progression and patient survival.
Main Methods:
- Utilized multiple databases to analyze KIF transcription levels in ACC.
- Correlated KIF expression with clinical data, overall survival (OS), first progression survival (FPS), and progression-free interval (PFI).
- Examined the association of KIFs with immune cell infiltration in ACC.
Main Results:
- Elevated expression of KIF4A, KIF11, KIF20A, and KIF22 was observed in ACC.
- These KIFs strongly correlated with ACC tumor advancement.
- KIF4A and KIF11 showed a positive correlation with immune cell infiltration.
Conclusions:
- KIF4A, KIF11, KIF20A, and KIF22 are implicated in ACC development and progression.
- These KIF genes offer potential as biomarkers for diagnosing and managing ACC.
- Understanding KIFs' role in immune infiltration provides a basis for novel therapeutic strategies.
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K

